Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

Terri S. Armstrong; Allison M. Bishof; Paul D. Brown; Martin Klein; MJB Taphoorn; Christina Theodore-Oklota

doi:https://doi.org/10.1093/neuonc/nov267

Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

Terri S. Armstrong, Allison M. Bishof, Paul D. Brown, Martin Klein, MJB Taphoorn, Christina Theodore-Oklota

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	1-12
Journal	Neuro-oncology
Volume	18
DOIs	https://doi.org/10.1093/neuonc/nov267
Publication status	Published - Mar 2016

Keywords

clinical outcomes assessment
glioblastoma
glioma
outcomes
signs and symptoms

Access to Document

https://doi.org/10.1093/neuonc/nov267

Cite this

@article{c7c736044a9d42689800c18c19c90a62,

title = "Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report",

keywords = "clinical outcomes assessment, glioblastoma, glioma, outcomes, signs and symptoms",

author = "Armstrong, {Terri S.} and Bishof, {Allison M.} and Brown, {Paul D.} and Martin Klein and MJB Taphoorn and Christina Theodore-Oklota",

year = "2016",

month = mar,

doi = "https://doi.org/10.1093/neuonc/nov267",

language = "English",

volume = "18",

pages = "1--12",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

AU - Armstrong, Terri S.

AU - Bishof, Allison M.

AU - Brown, Paul D.

AU - Klein, Martin

AU - Taphoorn, MJB

AU - Theodore-Oklota, Christina

PY - 2016/3

Y1 - 2016/3

KW - clinical outcomes assessment

KW - glioblastoma

KW - glioma

KW - outcomes

KW - signs and symptoms

U2 - https://doi.org/10.1093/neuonc/nov267

DO - https://doi.org/10.1093/neuonc/nov267

M3 - Article

C2 - 26989127

SN - 1522-8517

VL - 18

SP - 1

EP - 12

JO - Neuro-oncology

JF - Neuro-oncology

ER -